0001493152-22-010620.txt : 20220421 0001493152-22-010620.hdr.sgml : 20220421 20220421160546 ACCESSION NUMBER: 0001493152-22-010620 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20210420 FILED AS OF DATE: 20220421 DATE AS OF CHANGE: 20220421 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Waerness Trond Kydd CENTRAL INDEX KEY: 0001884098 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-13789 FILM NUMBER: 22841446 MAIL ADDRESS: STREET 1: 8000 INNOVATION PARKWAY CITY: BAON ROUGE STATE: LA ZIP: 70820 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Adhera Therapeutics, Inc. CENTRAL INDEX KEY: 0000737207 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 112658569 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: P.O. BOX 2161 CITY: WAKE FOREST STATE: NC ZIP: 27588 BUSINESS PHONE: 919-578-5901 MAIL ADDRESS: STREET 1: P.O. BOX 2161 CITY: WAKE FOREST STATE: NC ZIP: 27588 FORMER COMPANY: FORMER CONFORMED NAME: Marina Biotech, Inc. DATE OF NAME CHANGE: 20100722 FORMER COMPANY: FORMER CONFORMED NAME: MDRNA, Inc. DATE OF NAME CHANGE: 20080610 FORMER COMPANY: FORMER CONFORMED NAME: NASTECH PHARMACEUTICAL CO INC DATE OF NAME CHANGE: 19920703 3 1 ownership.xml X0206 3 2021-04-20 1 0000737207 Adhera Therapeutics, Inc. ATRX 0001884098 Waerness Trond Kydd 8000 INNOVATION PARKWAY BATON ROUGE LA 70820 1 0 0 0 Exhibit 24 - Power of Attorney /s/ Trond K. Waerness 2022-04-21 EX-24 2 ex-24.htm

 

Exhibit 24

 

POWER OF ATTORNEY

 

Know all by these presents that the undersigned hereby constitutes and appoints each of Andrew Kucharchuk and Michael D. Harris, signing singly, the undersigned’s true and lawful attorney-in-fact to do each of the following, provided, however, that the Power of Attorney shall not be used unless my signature is required and I am unavailable:

 

  (1) prepare and execute for and on behalf of the undersigned, in the undersigned’s capacity as an officer, director or 10% beneficial owner of securities of Adhera Therapeutics, Inc. (the “Company”), Forms 3, 4, and 5 in accordance with Section 16(a) of the Securities Exchange Act of 1934 (the “Exchange Act”) and the rules thereunder, and any other forms or reports the undersigned may be required to file in connection with the undersigned’s ownership, acquisition, or disposition of securities of the Company;
     
  (2) prepare and execute Forms 144 required to be filed under the Securities Act of 1933 (the “Securities Act”);
     
  (3) do and perform any and all acts for and on behalf of the undersigned which may be necessary or desirable to complete and execute any such Form 3, 4, or 5, or other form or report, and timely file such form or report with the United States Securities and Exchange Commission and any stock exchange or similar authority; and
     
  (4) take any other action of any type whatsoever in connection with the foregoing which, in the opinion of such attorney-in-fact, may be of benefit to, in the best interest of, or legally required by, the undersigned, it being understood that the documents executed by such attorney-in-fact on behalf of the undersigned pursuant to this Power of Attorney shall be in such form and shall contain such terms and conditions as such attorney-in-fact may approve in such attorney-in-fact’s discretion.

 

The undersigned hereby grants to each such attorney-in-fact full power and authority to do and perform any and every act and thing whatsoever requisite, necessary, or proper to be done in the exercise of any of the rights and powers herein granted, as fully to all intents and purposes as the undersigned might or could do if personally present, with full power of substitution or revocation, hereby ratifying and confirming all that such attorney-in-fact, or such attorney-in-fact’s substitute or substitutes, shall lawfully do or cause to be done by virtue of this Power of Attorney and the rights and powers herein granted. The undersigned acknowledges that the foregoing attorneys-in-fact, in serving in such capacity at the request of the undersigned, are not assuming, nor is the Company assuming, any of the undersigned’s responsibilities to comply with Section 16 of the Exchange Act.

 

This Power of Attorney shall remain in full force and effect until the undersigned is no longer required to file Forms 3, 4, and 5 with respect to the undersigned’s holdings of and transactions in securities issued by the Company, unless earlier revoked by the undersigned in a signed writing delivered to the foregoing attorneys-in-fact.

 

 
 

 

IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney to be executed as of this 20th day of April, 2022.

 

  /s/ Trond K. Waerness
  Signature
   
  Trond K. Waerness
  Print Name

 

2